Article: Other News To Note.

Article from:
BIOWORLD Today
Article date:
November 4, 2009
Copyright

Aastrom BioSciences Inc., of Ann Arbor, Mich., said the FDA granted orphan product status to the company's SC-I autologous bone marrow stems cells produced using the AastromReplicell system. Aastrom's therapeutic ex vivo-produced bone marrow stem cells received the orphan product designation for use in cancer patients requiring a stem cell transplant following high-dose chemotherapy, but who are unable to obtain sufficient numbers of blood stem cells for adequate treatment using current transplant methods. Aastrom's stock (NASDAQ:ASTM) rose 17 cents Thursday, or 58.6 percent, to close at 46 cents.

Antigenics Inc., of New York, said investigators enrolled the first ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Genomic Solutions -a Harvard ...
Business Wire;  January 7, 2003 ;     700+ words ... ... 7, 2002 Genomic Solutions, a subsidiary of Harvard Bioscience, Inc ... incorporate Genomic Solutions' ProFound ... President of Genomic Solutions, commented ... About Harvard Bioscience, Inc. Harvard ...

Article: Genomic Solutions Inc., a Harvard ...
Business Wire;  March 12, 2003 ;     700+ words ... ... 12, 2003 Genomic Solutions, Inc ... subsidiary of Harvard Bioscience, Inc ... majority of Genomic Solutions sales occur ... with the Genomic Solutions commercial ... HBIO, "Harvard Bioscience is a profitable ...

Article: Genomic Solutions, a Harvard ...
Business Wire;  March 3, 2003 ;     700+ words ... ... WIRE)--March 3, 2003 Genomic Solutions, Inc., a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO ... harvardbioscience.com. About Harvard Bioscience, Inc. Harvard Bioscience is a global developer ...

Article: Harvard Bioscience restructures Genomic ...
Instrument Business Outlook;  July 31, 2004 ;     700+ words ... ... conference call, Harvard Bioscience announced ... restructuring of its Genomic Solutions subsidiary ... stated Harvard Bioscience CEO Chane ... Replacing the Genomic Solutions' matrix ... company. Harvard Bioscience expects Genomic Solutions' sales ...

Article: Harvard Bioscience buys Genomic ...
Instrument Business Outlook;  July 31, 2002 ;     700+ words ... ... 02--Harvard Bioscience has announced ... will acquire Genomic Solutions for 3.2 ... quarter. Genomic Solutions will become ... in 2003. Harvard Bioscience CEO Chane ... commented that Genomic Solutions "will ultimately ...

Article: Harvard Bioscience and Genomic ...
Business Wire;  July 18, 2002 ;     700+ words ... ... 18, 2002 Today Harvard Bioscience, Inc. (NASDAQ: HBIO) and Genomic Solutions Inc. (NASDAQ ... restructuring. Genomic Solutions products provide ... Managing Director of Genomic Solutions Limited, UK) join ...

Article: Harvard Bioscience to purchase Genomic ...
Weekly Corporate Growth Report;  July 22, 2002 ;     519 words ... ... The Deal: Harvard Bioscience Inc. has ... to acquire Genomic Solutions Inc. in ... of 2002. Genomic Solutions is also restructuring ... Discussion: Genomic Solutions develops ... proteins. Harvard Bioscience is a global ...

Article: HARVARD BIOSCIENCE IN $26M DEAL AGREES TO ACQUIRE ...
The Boston Globe;  July 19, 2002 ;     452 words ...Harvard Bioscience Inc. yesterday ... agreed to buy Genomic Solutions Inc. in ... president of Harvard Bioscience. John Sullivan ... Boston, said Genomic Solutions invested ... Shares of Harvard Bioscience rose 61 cents ... shares of Genomic Solutions ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives